Supreme Pharmaceuticals Expands B2B Sales Model for Medical Marijuana, Supplying Premium Cannabis Cultivars - Video News Alert on Investmentpitch.com

June 07, 2016 11:14 AM EDT | Source: InvestmentPitch Media

Vancouver, British Columbia--(Newsfile Corp. - June 7, 2016) - Supreme Pharmaceuticals (CSE: SL) (OTC Pink: SPRWF) has further expanded its business to business sales model for medical marijuana. The company has entered into a letter of intent with a Canadian Licensed Producer to supply, on a long-term basis, multiple premium cannabis cultivars, which will be grown to maturity by the licensed producer.


InvestmentPitch Media has produced a "video news alert" which provides a brief overview of the company. If this link is not enabled, please visit www.InvestmentPitch.com and enter "Supreme" in the search box.

This agreement is conditional upon the usual regulatory approvals, execution of documents and other customary closing conditions.

The company is focussed on becoming a leading supplier of affordable medical cannabis through its wholly-owned subsidiary 7 Acres, a federally licensed producer of medical marijuana. 7 Acre operates a 342,000 sq. ft. hybrid greenhouse facility in Kincardine, Ontario, which combines the best technology of indoor production with the efficiencies and sustainability of a greenhouse, in a single large-format production footprint.

John Fowler, CEO of Supreme, stated: "Last month we announced the commencement of our business-to-business sales model by entering into LOIs for the sale of dried marihuana to five fully licensed Canadian LPs. Today marks the commencement of the second leg of our business: supply of high quality cannabis genetics to other LPs. The genetics business diversifies our revenue while remaining committed to supporting the aggregate growth of the legal cannabis industry in Canada."

In April, 2016 Supreme entered into a Strategic Alliance Agreement with Spanish-based Dinafem Seeds, one of the world's leading manufacturers of high quality cannabis seeds.

Management believes that cannabis genetics are essential to Supreme's business as the best genetics create higher quality crops, increase yields and decrease operational risks. Canadian Licensed Producers or applicant companies interested in receiving genetic starting materials should visit www.7acres.com or email wholesale@supreme.ca.

The company recently raised approximately $3.1 million from the exercise of warrants under a special incentive program. Proceeds are being utilized for general working capital purposes as 7 Acres moves through the cultivation stage in advance of anticipated revenues in Q4 of 2016, again, subject to regulatory approval.

For more information, please visit the company's website, www.supreme.ca, contact investor relations at 416-630-7272 or email info@supreme.ca.

About InvestmentPitch Media

InvestmentPitch Media is arguably the largest producer and distributer of video news content, primarily for small and mid-cap companies. The company specializes in producing short videos based on significant news releases, research reports and other content of interest to investors.

CONTACT:

InvestmentPitch Media
Barry Morgan, CFO
bmorgan@investmentpitch.com

info